SCHEMBL6979535

SCHEMBL6979535

COC(OCC[Si](C)(C)C)c1cccc(OCc2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 1/20 0.39
GRM5 P41594 2/20 0.35
FFAR1 O14842 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPK1 P28482 2/20 0.34
MAOB P27338 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
NUDT1 P36639 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
PTGES O14684 1/20 0.33
ALOX5 P09917 1/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981819 0.75 PDE4A (0.35)
SCHEMBL6983802 0.75 L3MBTL1 (0.33) ALDH1A1HPGDTSHRL3MBTL1GAA
SCHEMBL6984258 0.75
SCHEMBL20085570 0.74 TRPV3 (0.51) TRPV3ALDH1A1MAPK1MAOBLMNA
SCHEMBL28408442 0.72 TRPV3 (0.49) TRPV3GRM5ALDH1A1MAPK1MAOB
SCHEMBL2524154 0.72 L3MBTL1 (0.52) TRPV3GRM5MAPK1MAOBLMNA
SCHEMBL17459263 0.70 MAOB (0.53) TRPV3ALDH1A1MAPK1MAOBLMNA
SCHEMBL31375611 0.70 MAOB (0.53) TRPV3ALDH1A1MAPK1MAOBLMNA
SCHEMBL6979538 0.70 TRPV3 (0.46) TRPV3GRM5MAPK1LMNAHTT
SCHEMBL29285233 0.69 FFAR1 (0.46) TRPV3GRM5FFAR1PKMPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946546-B1 PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, METHOD OF PREPARING AND APPLICATION AS MEDICINE PF MEDICAMENT (FR) 2003-06-25 EP disclosed
US-6020345-A Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine PIERRE FABRE MEDICAMENT (FR) 2000-02-01 US disclosed
EP-0946546-A1 PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, METHOD OF PREPARING AND APPLICATION AS MEDICINE PIERRE FABRE MEDICAMENT (FR) 1999-10-06 EP disclosed
WO-1998022459-A1 PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, METHOD OF PREPARING AND APPLICATION AS MEDICINE PIERRE FABRE MEDICAMENT (FR) 1998-05-28 WO disclosed